You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

GW685698/GW642444

Showing 1 - 25 of 115
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pulmonary Disease, Chronic Obstructive Trial in United States (Placebo, GSK233705/GW642444)

Completed
Has Results
  • Pulmonary Disease, Chronic Obstructive
  • Mobile, Alabama
  • +11 more
Aug 18, 2020

Asthma Trial (FF/UMEC/VI, ELLIPTA, FF/VI)

Not yet recruiting
  • Asthma
  • (no location specified)
Feb 24, 2023

Pulmonary Disease, Chronic Obstructive Trial in United States (Batefenterol + Fluticasone Furoate, Placebo, Albuterol)

Completed
Has Results
  • Pulmonary Disease, Chronic Obstructive
  • Batefenterol + Fluticasone Furoate
  • +2 more
  • Phoenix, Arizona
  • +9 more
Jul 13, 2020

Asthma Trial in Worldwide (FF/VI via ELLIPTA DPI, FF via ELLIPTA DPI)

Completed
Has Results
  • Asthma
  • FF/VI via ELLIPTA DPI
  • FF via ELLIPTA DPI
  • Hoover, Alabama
  • +183 more
Sep 12, 2022

Asthma Trial in United Kingdom (fluticasone furoate + vilanterol, inhaled corticosteroid with or without a long acting

Completed
Has Results
  • Asthma
  • fluticasone furoate + vilanterol
  • inhaled corticosteroid with or without a long acting beta2-agonist
  • Altrincham, Cheshire, United Kingdom
  • +179 more
Jul 26, 2018

Rhinitis, Allergic, Seasonal Trial (GW685698X Aqueous Nasal Spray)

Completed
  • Rhinitis, Allergic, Seasonal
  • GW685698X Aqueous Nasal Spray
  • ,
    GSK Investigational Site
Aug 30, 2018

Arnuity® Ellipta® Drug Use Investigation

Completed
  • Asthma
  • Arnuity Ellipta
  • Hokkaido, Japan
  • +1 more
Apr 22, 2021

Asthma Trial in France, Germany (Fluticasone Furoate, Vilanterol, Fluticasone propionate)

Completed
Has Results
  • Asthma
  • Fluticasone Furoate
  • +5 more
  • Amiens, France
  • +92 more
Jul 5, 2018

Pulmonary Disease, Chronic Obstructive Trial in Worldwide (fluticasone furoate (FF, GW685698)/vilanterol (VI, GW642444) 100/25

Completed
Has Results
  • Pulmonary Disease, Chronic Obstructive
  • fluticasone furoate (FF, GW685698)/vilanterol (VI, GW642444) 100/25 mcg Novel Dry Powder Inhaler (NDPI)
  • Tiotropium
  • Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina
  • +54 more
Jan 18, 2018

Asthma Trial in Randwick, Sydney (GW685698X & GW642444M)

Completed
  • Asthma
  • GW685698X & GW642444M
  • Randwick, Sydney, New South Wales, Australia
    GSK Investigational Site
Aug 2, 2017

Rhinitis, Allergic, Seasonal Trial (GW685698)

Completed
  • Rhinitis, Allergic, Seasonal
  • ,
    GSK Investigational Site
Aug 30, 2018

Asthma Trial in Randwick (Fluticasone foroate/ vilanterol, Fluticasone foroate, Vilanterol)

Completed
  • Asthma
  • Fluticasone foroate/ vilanterol
  • +3 more
  • Randwick, New South Wales, Australia
    GSK Investigational Site
Aug 16, 2017

Pulmonary Disease, Chronic Obstructive Trial in Norway, Sweden (GW685698/GW642444)

Completed
Has Results
  • Pulmonary Disease, Chronic Obstructive
  • GW685698/GW642444
  • Bergen, Norway
  • +8 more
Oct 26, 2016

Pulmonary Disease, Chronic Obstructive Trial in Worldwide (GW642444, Placebo)

Completed
Has Results
  • Pulmonary Disease, Chronic Obstructive
  • Camperdown, New South Wales, Australia
  • +13 more
Mar 7, 2018

Pulmonary Disease, Chronic Obstructive Trial in Worldwide (FF/GW642444 Inhalation Powder, FF Inhalation Powder, GW642444

Completed
Has Results
  • Pulmonary Disease, Chronic Obstructive
  • FF/GW642444 Inhalation Powder
  • +3 more
  • Mobile, Alabama
  • +131 more
Jun 14, 2018

Pulmonary Disease, Chronic Obstructive Trial in Worldwide (125/25 mcg once-daily GSK573719/GW642444, 125mcg once-daily

Completed
Has Results
  • Pulmonary Disease, Chronic Obstructive
  • 125/25 mcg once-daily GSK573719/GW642444
  • +2 more
  • Mobile, Alabama
  • +53 more
Apr 30, 2018

Pulmonary Disease, Chronic Obstructive Trial in Worldwide (FF/GW642444 Inhalation Powder, GW642444 Inhalation Powder)

Completed
Has Results
  • Pulmonary Disease, Chronic Obstructive
  • FF/GW642444 Inhalation Powder
  • GW642444 Inhalation Powder
  • Birmingham, Alabama
  • +182 more
Aug 2, 2018

Pulmonary Disease, Chronic Obstructive Trial in Worldwide (GSK573719/GW642444 125/25, GSK573719/GW642444 62.5/25, GSK573719 125)

Completed
Has Results
  • Pulmonary Disease, Chronic Obstructive
  • GSK573719/GW642444 125/25
  • +5 more
  • Jasper, Alabama
  • +52 more
Jan 18, 2018

Pulmonary Disease, Chronic Obstructive Trial in London (GSK233705, GW642444, GSK233705 and GW642444)

Completed
  • Pulmonary Disease, Chronic Obstructive
  • London, United Kingdom
    GSK Investigational Site
Oct 2, 2017

Asthma Trial in Worldwide (Fluticasone Furoate/GW642444, Fluticasone propionate)

Completed
Has Results
  • Asthma
  • Fluticasone Furoate/GW642444
  • Fluticasone propionate
  • Oxford, Alabama
  • +46 more
Jan 18, 2018

Pulmonary Disease, Chronic Obstructive Trial in United States (Fluticasone Furoate (FF)/GW642444 Inhalation Powder, )

Completed
Has Results
  • Pulmonary Disease, Chronic Obstructive
  • Fluticasone Furoate (FF)/GW642444 Inhalation Powder
  • placebo
  • DeLand, Florida
  • +7 more
Oct 9, 2017

Asthma Trial (GW685698X)

Completed
  • Asthma
  • (no location specified)
Oct 31, 2017

Pulmonary Disease, Chronic Obstructive Trial in Worldwide (GSK573719/GW642444 125/25, GSK573719/GW642444 62.5/25, GW642444)

Completed
Has Results
  • Pulmonary Disease, Chronic Obstructive
  • GSK573719/GW642444 125/25
  • +3 more
  • Birmingham, Alabama
  • +96 more
Jan 18, 2018

Asthma Trial in Randwick (fluticasone furoate//GW642444, fluticasone furoate, GW642444)

Completed
  • Asthma
  • fluticasone furoate//GW642444
  • +2 more
  • Randwick, New South Wales, Australia
    GSK Investigational Site
Jun 9, 2017

Pulmonary Disease, Chronic Obstructive Trial in United States (500mcg/25mcg once daily, Placebo once daily)

Completed
Has Results
  • Pulmonary Disease, Chronic Obstructive
  • 500mcg/25mcg once daily
  • Placebo once daily
  • Chester, South Carolina
  • +3 more
Oct 9, 2017